Olaparib Gains Reimbursement in Italy for Advanced Pancreatic Cancer with BRCA Mutations A new treatment option is now available for patients in Italy battling metastatic pancreatic cancer with BRCA1/2 mutations. …
Tag:
Pancreas
-
-
Latest Chemotherapy Combination Shows Promise for Pancreatic Cancer Patients Bologna, Italy – February 23, 2026 – A novel chemotherapy regimen is offering renewed hope for individuals battling pancreatic cancer, potentially …
-
Olaparib Receives Reimbursement for Advanced Pancreatic Cancer with BRCA Mutations The Italian Medicines Agency (AIFA) has approved the reimbursement of olaparib, a PARP inhibitor, for the maintenance treatment of patients …
-
‘Cyborg’ Organoid Advances Diabetes Research Scientists have developed a novel “cyborg” organoid – a combination of living pancreatic islet cells and flexible electronic devices – that promises to revolutionize the …
Older Posts